The role of β-lactam/β-lactamase inhibitor combinations in surgical infections

Surgical Infections

Volumn 2, Issue SUPL. 1, 2001, Pages

  Sayek, Iskender ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMINOPENICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFOXITIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; GENTAMICIN; METRONIDAZOLE; NAFCILLIN; PENICILLIN G DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; SULTAMICILLIN; TAZOBACTAM;

ABDOMINAL INFECTION; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; ARTICLE; BRAIN ABSCESS; CLINICAL STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETIC FOOT; GYNECOLOGIC DISEASE; HUMAN; INCIDENCE; MIXED INFECTION; MONOTHERAPY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL INFECTION; WOUND INFECTION;

EID: 0035683249     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2001.2.s1-23     Document Type: Article

References (43)

1. Management of intraabdominal infections
2. Microbiology and mortality of brain abscess in Newcastle-upon-Tyne between 1979 and 1988
3. Clinical and pharmacokinetics characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients
4. Use of aminoglycoside antibiotics in surgical infections
5. Serum level monitoring of aminoglycoside antibiotics. Limitations in intensive care unit-related bacterial pneumonia
6. The influence of dose frequency and agent toxicity on the cost of parenteral antibiotic therapy
7. Treatment of intraabdominal infections is appropriate with single-agent or combination therapy
8. A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed aerobic-anaerobic infections
9. A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis
10. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections
11. Comparison of cefoperazone plus sulbactam with clindamycin plus gentamicin as treatment for intraabdominal infections
12. A randomized study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections
13. Treatment options for early intraabdominal infections
14. A randomized controlled trial of ampicillin plus sulbactam versus gentamicin plus clindamycin in the treatment of intraabdominal infections: A preliminary report
15. Efficacy and safety of sulbactam/cefoperazone for hepato-biliary infections
16. Efficacy of a beta-lactamase inhibitor combination in serious intraabdominal infections
17. A non-comparative study of parenteral ampicillin and sulbactam in intra-thoracic and intra-abdominal infections
18. Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field
19. Piperacillin/tazobactam compared with cefuroxime/metronidazole in the treatment of intra-abdominal infections
20. Evaluation of antibiotic therapy following penetrating abdominal trauma
21. The efficacy of cefoxitin vs. clindamycin/gentamicin in surgically treated stab wounds of the bowel
22. Treatment of mixed aerobic-anaerobic infections of the female genital tract
23. Basic and clinical study of sulbactam/cefoperazone on the obstetric/gynecology field
24. Sulbactam/ampicillin versus cefoxitin in the treatment of gynaecological infections: An antibiotic therapeutic study
25. Ampicillin/sulbactam vs. clindamycin/gentamicin in the treatment of postpartum endometritis
26. Brain abscesses. A study of 45 consecutive cases
27. Fifteen year review of mortality of brain abscess
28. Successful treatment of multiple brain abscesses with antibiotics alone
29. Treatment of intracranial abscesses: Experience with sulbactam/ampicillin
30. Diabetic foot infections
31. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients
32. Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections
33. Antimicrobial prophylaxis in surgery
34. Abdominal surgical wound infection is lowered with improved perioperative enterococcus and bacteroides therapy
35. Pharmacokinetics of ampicillin/sulbactam in patients undergoing colorectal surgery: Measurements in serum, the colonic wall and in tissue at the incision site
36. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery. The need for Gram-negative coverage
37. Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin + aminoglycoside combination therapy for treatment of serious lower respiratory, intraabdominal, gynecologic, and urinary tract infections
38. Antibiotic cost analysis in patients with abdominal stab wounds
39. Imipenem/cilastatin versus gentamicin/clindamycin: A cost effectiveness study
40. Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection: Comparative cost-effectiveness
41. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections
42. Epidemiology and economic impact of the diabetic foot - A major health care problem
43. Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients